Follow

Stem cell models derived from patients with Parkinson’s disease are valuable tools that are helping researchers around the world to better understand the underlying causes of neurodegeneration and to develop biomarkers and new therapies. In this episode, Dr. Birgitt Schüle discussed her work developing alpha-synuclein cell lines, challenges/opportunities in the field, and important considerations for open science.

michaeljfox.org/podcast/episod

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.